VAERS 1631609
MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 02NA21A
- Staat
- -
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 25.08.2021
- Impfdatum
- 02.03.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / LA
Symptomtext
body aches; fatigue; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (fever) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02NA21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) for Asthma, CEFUROXIME (MAXIM [CEFUROXIME]) for Indigestion. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body aches), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (fever). At the time of the report, MYALGIA (body aches), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 101 degree f (abnormal) 101 degree F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No information regarding corrective treatment was reported by the patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210303; Test Name: Body temperature; Result Unstructured Data: 101 degree F
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- MAXIM [CEFUROXIME]; BREO ELLIPTA
- Allergien
- -
- Vorherige Impfungen
- -